FAQ

Seasonal trivalent influenza vaccine, adjuvanted, preservative free

Known as: influenza, trivalent, adjuvanted 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2002-2018
01220022018

Related topics

Related topics

2 relations
Novartis Pharmaceutical CorporationSeqirus

Related mentions per year

Related mentions per year

1950-2018
1960198020002020
Seasonal trivalent influenza vaccine, adjuvanted, preservative free
Seqirus
Novartis Pharmaceutical Corporation

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Intradermal immunization with inactivated swine influenza virus and adjuvant polydi(sodium carboxylatoethylphenoxy)phosphazene (PCEP) induced humoral and cell-mediated immunity and reduced lung viral…
Swine influenza virus is endemic worldwide and it is responsible for significant economic losses to the swine industry. A vaccine… (More)
Is this relevant?
2014
2014
A Full-Length Plasmodium falciparum Recombinant Circumsporozoite Protein Expressed by Pseudomonas fluorescens Platform as a Malaria Vaccine Candidate
The circumsporozoite protein (CSP) of Plasmodium falciparum is a major surface protein, which forms a dense coat on the… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2011
2011
Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial.
BACKGROUND Effective antigen-sparing vaccines are needed to confront pandemic influenza. Whole-virion and oil-in-water adjuvanted… (More)
Is this relevant?
2011
2011
Immunoadjuvant effects of hemagglutinating virus of Japan envelope (HVJ-E) on the inactivated H9 subtype avian influenza virus vaccine.
Avian influenza viruses (AIV) of the H9 subtype cause serious health problems in chickens, resulting in great economic losses to… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2006
2006
Mucosal vaccine targeting improves onset of mucosal and systemic immunity to botulinum neurotoxin A.
Absence of suitable mucosal adjuvants for humans prompted us to consider alternative vaccine designs for mucosal immunization… (More)
Is this relevant?
2006
2006
Maternal immunization by egg propagated gametocyte vaccine to control Eimeria tenella infections in newly hatched chicks
The present paper reports the ability of egg-propagated gametocyte vaccine to induce protective immunity against Eimeria tenella… (More)
  • figure 1
Is this relevant?
2005
2005
Nasal boost with adjuvanted heat-killed BCG or arabinomannan-protein conjugate improves primary BCG-induced protection in C57BL/6 mice.
Today it is generally accepted that the Bacillus Calmette-Guerin (BCG) vaccine protects against childhood tuberculosis (TB) but… (More)
Is this relevant?
2002
2002
Immunogenicity of a recombinant varicella-zoster virus gE-IE63 fusion protein, a putative vaccine candidate against primary infection and zoster reactivation.
The varicella-zoster virus (VZV) envelope glycoprotein E (gE) and immediate early protein 63 (IE63) are well known targets for… (More)
Is this relevant?